Paper42201051
Beyond the Scan: Adapting Multimodal Lung Cancer Screening for Central and Eastern Europe-Overcoming Systemic Barriers and Epidemiological Confounders.
Anghel R and 8 others. Med Sci (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Beyond the Scan: Adapting Multimodal Lung Cancer Screening for Central and Eastern Europe-Overcoming Systemic Barriers and Epidemiological Confounders. Papers, record 42201051. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42201051
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Beyond the Scan: Adapting Multimodal Lung Cancer Screening for Central and Eastern Europe-Overcoming Systemic Barriers and Epidemiological Confounders.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung Neoplasms | Major topic |
| Early Detection of Cancer | Major topic |
| Mass Screening | Major topic |
| Humans | |
| Europe, Eastern | |
| Hungary | |
| Tomography, X-Ray Computed | |
| Risk Factors |
Source PubMed
References262
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21714641 | Reduced lung-cancer mortality with low-dose computed tomographic screening. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21714641 | PubMed |
| 2 | 31817261 | Standard Expected Years of Life Lost Due to Malignant Neoplasms in Poland, 2000-2014. | Int J Environ Res Public Health | 2019 | https://conductscience.org/library/papers/31817261 | PubMed |
| 3 | 29641468 | Associations of Mediterranean Diet and a Posteriori Derived Dietary Patterns with Breast and Lung Cancer Risk: A Case-Control Study. | Nutrients | 2018 | https://conductscience.org/library/papers/29641468 | PubMed |
| 4 | 33215430 | Can life satisfaction be considered a predictor of quality of life in patients with lung cancer? | Eur Rev Med Pharmacol Sci | 2020 | https://conductscience.org/library/papers/33215430 | PubMed |
| 5 | 29801465 | Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29801465 | PubMed |
| 6 | 35369633 | The effect of the RadioProtect cosmetic formulation on the skin of oncological patients treated with selected cytostatic drugs and ionizing radiation. | Postepy Dermatol Alergol | 2022 | https://conductscience.org/library/papers/35369633 | PubMed |
| 7 | 40943939 | EBUS-TBNA for Diagnosis and Staging of Lung Cancer: A Retrospective Regional Analysis Integrating Clinical and Molecular Data (EXPoSURE Score). | J Clin Med | 2025 | https://conductscience.org/library/papers/40943939 | PubMed |
| 8 | 41020868 | Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41020868 | PubMed |
| 9 | 35601926 | Implementing Lung Cancer Screening in Europe: Taking a Systems Approach. | JTO Clin Res Rep | 2022 | https://conductscience.org/library/papers/35601926 | PubMed |
| 10 | 27105879 | The Frequency of EGFR Mutation in Lung Adenocarcinoma and the Efficacy of Tyrosine Kinase Inhibitor Therapy in a Hungarian Cohort of Patients. | Pathol Oncol Res | 2016 | https://conductscience.org/library/papers/27105879 | PubMed |
| 11 | 24501604 | High costs as a slow down factor of thoracoscopic lobectomy development in Poland - an institutional experience. | Wideochir Inne Tech Maloinwazyjne | 2013 | https://conductscience.org/library/papers/24501604 | PubMed |
| 12 | 25884958 | Availability and outcomes of radiotherapy in Central Poland during the 2005-2012 period - an observational study. | BMC Cancer | 2015 | https://conductscience.org/library/papers/25884958 | PubMed |
| 13 | 40724620 | Beyond Comorbidity: Pulmonary Adenocarcinoma in a Patient with Rheumatoid Arthritis-A Case Report and Literature Review. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40724620 | PubMed |
| 14 | 30510781 | A country wide adaptation of the European Society of Thoracic Surgeons lung cancer core database: the Hungarian model. | J Thorac Dis | 2018 | https://conductscience.org/library/papers/30510781 | PubMed |
| 15 | 21303801 | European cancer mortality predictions for the year 2011. | Ann Oncol | 2011 | https://conductscience.org/library/papers/21303801 | PubMed |
| 16 | 36277960 | EGFR T790M Mutation Detection in Patients With Non-Small Cell Lung Cancer After First Line EGFR TKI Therapy: Summary of Results in a Three-Year Period and a Comparison of Commercially Available Detection Kits. | Pathol Oncol Res | 2022 | https://conductscience.org/library/papers/36277960 | PubMed |
| 17 | 39529341 | Evaluation of epidemiological and pathological features of symptomatic spinal metastases in Romania - what could we learn from a retrospective study? | Rom J Morphol Embryol | 2024 | https://conductscience.org/library/papers/39529341 | PubMed |
| 18 | 39510703 | Lung Cancer in Romania. | J Thorac Oncol | 2024 | https://conductscience.org/library/papers/39510703 | PubMed |
| 19 | 35410926 | Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study. | BMJ Open | 2022 | https://conductscience.org/library/papers/35410926 | PubMed |
| 20 | 23900869 | Morphological characteristics of potentially malignant pulmonary nodules in high-risk male smokers detected in lung cancer screening trial in Cracow, Poland. | Pol J Pathol | 2013 | https://conductscience.org/library/papers/23900869 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42201051
GET https://conductscience.org/api/papers/v1/42201051/references?page=2